Review Article

Potential Benefits of Therapeutic Use of β2-Adrenergic Receptor Agonists in Neuroprotection and Parkinson’s Disease

Figure 2

Molecular mechanism of the inhibitory function of salmeterol-mediated β2AR activation.
103780.fig.002